诚意药业(603811.SH)：托拉塞米片获得药品注册证书

Core Viewpoint - Chengyi Pharmaceutical (603811.SH) has received approval from the National Medical Products Administration for the registration of Torasemide tablets, which are indicated for the treatment of edema related to heart failure, kidney diseases, or liver diseases, and can be used alone or in combination with other antihypertensive medications [1] Group 1 - The product, Torasemide tablets, is approved for treating edema associated with heart failure, kidney diseases, or liver diseases [1] - The medication can also be used for the treatment of hypertension, either as a standalone treatment or in conjunction with other antihypertensive drugs [1]